Angion Biomedica Corp.
ANGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $12,203 | $25,981 | $24,381 | $81,910 |
| - Cash | $17,618 | $0 | $50,487 | $88,756 |
| + Debt | $6,006 | $0 | $3,710 | $4,662 |
| Enterprise Value | $591 | $25,981 | -$22,396 | -$2,184 |
| Revenue | $0 | – | $2,301 | $28,312 |
| % Growth | – | – | -91.9% | – |
| Gross Profit | $0 | – | $2,301 | $27,879 |
| % Margin | – | – | 100% | 98.5% |
| EBITDA | -$44,986 | – | -$20,118 | -$55,619 |
| % Margin | – | – | -874.3% | -196.5% |
| Net Income | -$51,898 | – | -$55,700 | -$53,772 |
| % Margin | – | – | -2,420.7% | -189.9% |
| EPS Diluted | -4.25 | – | -1.85 | -1.9 |
| % Growth | – | – | 2.6% | – |
| Operating Cash Flow | -$37,068 | -$32,694 | -$38,390 | -$52,643 |
| Capital Expenditures | -$87 | -$66 | $0 | -$382 |
| Free Cash Flow | -$37,155 | -$32,760 | -$38,390 | -$53,025 |